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The molecular conformation of a bis-helicenic terpyridine 
system is strongly modified upon binding to Zn(II) ion, a 
process that is accompanied by large changes in the optical 
and chiroptical properties. This system affords a new type of 
helicene-based chiroptical switching. 10 
  
 The contribution of chiroptical molecular switches1 to the field 
of functional devices is stimulated by many potential applications 
such as molecular information processing, data storage, or probes 
for the detection of chirality.2 Interconversion between two or 15 
more stable chiral forms can result from responses of chiral 
molecules to external stimuli such as heat, light, pressure, 
solvent, pH, change in redox potential or presence of chemicals.  
The response at the molecular level can be transduced to a read-
out process through the effect on chiroptical activity; e.g., optical 20 
rotation, electronic circular dichroism (ECD), and circularly 
polarized luminescence (CPL). Efficient, practicable switching 
between two (or more) molecular states, is based on stability, 
non-destructive read-out, fast response times, reproducibility and 
fatigue resistance. An important requirement is a large response 25 
difference between the states to ensure unambiguous read-out.  
 In the last decade, helicenes have appeared as attractive 
candidates for molecular materials and chiroptical switches due to 
their helical -conjugated structure which gives rise to strong 
chiroptical properties such as huge optical rotation values, intense 30 
ECD spectra and significant CPL activity.3  Examples of 
helicene-based chiroptical switches have been recently reviewed.4 
However, the creation of structural diversity is still necessary to 
develop new kinds of functions in helicene-based chiral systems 
and to create innovative molecular devices. In this regard, several 35 
transition-metal complexes formed from helical -conjugated 
ligands have recently been shown to display unprecedented 
chiroptical and electronic properties that are switchable by redox 
or acid/base stimuli.5 While in those examples the helical 
topology and integrity of the chemical backbone was maintained 40 
upon switching, constructing a scaffold in which movements can 
take place through geometrical and conformational changes is 
particularly appealing. Such conformational changes in chiral 
systems may lead to molecular motors with effective 
unidirectional motion.2,6  45 
In this communication, we describe the synthesis of the first 
bis-helicenic terpyridine ligand (meso-, (M,M)- and (P,P)-1 in 
Scheme 1) acting as a chiroptical switch upon reversible 
coordination-decoordination to zinc(II). The profound 
conformational changes induced lead to a multi-output read-out 50 
system, showing responses in ECD, fluorescence and CPL-
activity. The (chir)optical changes accompanying the 
interconversion between the ligand and zinc-complexed states 
have been analyzed via first-principles calculations.  
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Scheme 1. Synthesis of bis-helicenic terpyridine 1. i) n-BuLi, THF, r.t., 5 h, 
82%; ii) h, cat. I2, toluene/THF, r.t., 7 h, 45%.  
 The synthesis of ligand 1 was accomplished as described in 
Scheme 1. First, a Wittig reaction between terpyridine bis-
aldehyde 27a and (benzo[c]phenanthren-3-ylmethyl)triphenyl-75 
phosphonium bromide 37b yielded bis-olefin 4 as a mixture of 
three isomers (E,E - major compound, Z,Z, and E,Z). Subsequent 
photo-irradiation (700 W Hg lamp) in a toluene/THF mixture at 
room temperature (r.t.) in the presence of catalytic iodine, 
furnished bis-helicene-terpyridine 1 as a statistical mixture of 80 
(M,P)-1 (meso-1) and racemic (P,P)- and (M,M)-1. The structure 
of meso-1 was confirmed by NMR spectroscopy and by X-ray 
diffraction studies. The 1H NMR spectrum is in agreement with 
its Cs symmetry and displays the typical signature of [6]helicene 
derivatives such as for example degenerate triplets at 6.8 and 7.3 85 
ppm corresponding to H15 and H14, respectively (see Electronic 
Supplementary Information, ESI). Thanks to its low solubility, 
meso-1 easily crystallized in the centrosymmetric Ccm21 space 
group, with the nitrogen atoms of adjacent pyridyl rings disposed 
trans to one another, as is usual in 2,2':6',2''-terpyridines (Scheme 90 
2a).8 The structure also confirms (i) the Cs symmetry of the 
achiral meso compound; (ii) the high degree of planarity of the 
  
terpy moiety (dihedral angles between the different pyridine rings 
< 6.5°); and (iii) values for the helical angle (angle between the 
terminal rings) of the azahelicene moieties that are typical of such 
units (51.83°).3 
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Scheme 2. a) Coordination of achiral ligand meso-1 to Zn2+, generating 15 
meso-1·Zn(OAc)2 and their respective X-ray crystal structures. b) X-ray 
structure and supramolecular arrangement of (P,P)-1 along the x axis in 
the solid state. 
 Pure samples of (M,M)- and (P,P)-1 were successfully 
obtained from the crude stereoisomeric mixture by using HPLC 20 
over a chiral stationary phase and were then fully characterized 
(see ESI). They display different 1H NMR spectra from the meso-
1 compound in agreement with different orientation of helicenic 
moieties (for instance H15 and H14 resonate at 6.7 and 7.1, ppm, 
respectively). The X-ray structure of (P,P)-1 (P21221 space 25 
group; Scheme 2b) shows (i) C2 symmetry as opposed to the Cs 
symmetry of the meso isomer; (ii) again a high degree of 
planarity within the terpy moiety (dihedral angles between the 
pyridine rings < 8.3°) and a trans disposition of N atoms in 
adjacent rings; and (iii) typical values for the helical angle of the 30 
azahelicene moieties (60.84°).3 Furthermore, compound (P,P)-1 
displays intermolecular organization along the x axis thanks to 
the presence of  interactions (centroid-centroid distances 3.67 
Å; Scheme 2a). 
  Compounds meso-1 and (P*,P*)-1# display photophysical 35 
properties with similar characteristics to one another (see ESI). 
For example, the UV-visible spectra of these two compounds 
show a very strong absorption band centred at about 320 nm 
( 6  104 M–1 cm–1) and a set of bands extending into the 
visible region, of gradually diminishing intensity, of which the 40 
longest wavelength appears at 416 nm (= 5 – 8  103 M–1 cm–1). 
(P*,P*)-1# displays intense blue fluorescence in CH2Cl2 at r.t. 
(max = 421 nm,  = 8.4%, = 5.7 ns). Its structured emission 
spectrum is characterised by a vibronic progression of 
~ 1350 cm–1, with the maximum intensity being in the 0-0 band, 45 
indicative of a rigid aromatic fluorophore. In a frozen glass at 77 
K, the fluorescence is accompanied by long-lived green 
phosphorescence (max
 = 532 nm = 1.4 s), with similar 
vibrational structure. Similar spectra were recorded for meso-1. 
The emission properties are in line with previously described 50 
nitrogen-containing [6]helicene derivatives.5d 
 The chiroptical properties of (M,M)- and (P,P)-1 were then 
studied. High specific and molar optical rotation values were 
obtained ((P,P)-1:  23D = +2150,  
23
D = +15790 (±5%, CH2Cl2, 
2.2  10-4 M). The  molar rotations are twice as high as for 4-55 
aza[6]helicene (  23D = +2290,  
23
D = +7735 ° cm
2/dmol (± 5%, 
CH2Cl2, C 1.7 g/100mL))
9 in agreement with the presence of two 
azahelicene moieties. Similarly, very strong mirror-image ECD 
spectra were recorded for (M,M)- and (P,P)-1 enantiomers 
(Figure 1), with a strong negative band around 264 nm ( = -280 60 
M-1 cm-1) and strong positive one at 341 (+388 M-1 cm-1) for the 
(P,P)-1 enantiomer. Interestingly, a clear substructure is 
appearing and is assigned to a vibronic progression (~ 1350 cm–1, 
C=C stretching bands). A weak positive ECD band ( = +21 M–
1 cm–1) is also present at 420 nm. 65 
 CPL activity is another appealing chiroptical property of 
organic chiral chromophores such as helicenic derivatives and has 
been examined recently by us and others.10 Indeed (M,M)- and 
(P,P)-1 enantiomers demonstrated mirror-imaged CPL spectra 
(Figure S20) with opposite glum values ((P,P)-1: +8.6  10
-3 and 70 
(M,M)-1: -8.4  10-3) around the emission maximum (~ 420 nm). 
These values are slightly stronger than for related molecules such 
as helicene-bipyridine derivatives (glum ~ ±10
-3)5d or other CPL-
active organic molecule.11 
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Figure 1. Experimental ECD spectra of enantiopure (M,M)- and (P,P)-1 
and its Zn(II) complex (P,P)-1·Zn(OAc)2 (CH2Cl2,  2  10
–5 M). Inset: 85 
Simulated spectra of (P,P)-1 (trans and cis) and (P,P)-1·Zn(OAc)2 (see ESI). 
  The terpyridine system is a good scaffold for coordination to a 
variety of transition-metal centers yielding complexes with a rich 
variety of photophysical properties that may be appealing for 
device applications.8,12 Rarely have chiral substituents been 90 
integrated within the terpy scaffold and used as chiroptical 
switches or chiral sensors.13 In 2004, Lehn et al. described a two-
state switching system based on a terpyridine-type receptor which 
was activated towards substrate binding upon complexation of a 
zinc(II) cation.12a This process was based on so-called 95 
"nanomechanical motions" induced by ion binding and  involving 
shape switching between two forms presenting different 
physicochemical properties, namely the metal-bound and the 
metal-free states. Inspired by this seminal work, we explored how 
Zn(II) binding to 1 could induce chemical switching of the 100 
(chir)optical properties through the large conformational changes 
associated with the switch from W- to U-shape geometries of the 
terpy moiety (Figure 2b). 
 In the first instance, meso-1·Zn(OAc)2 complex was prepared  
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Figure 2. a) Reversible Zn(II) complexation-decomplexation process of (P,P)-1 using Zn(OAc)2 and TPEN as the chemical stimuli. b) Schematic 
modification of the geometry. c) Evolution of the UV-vis spectrum of (P*,P*)-1# (3  10-5 M, CH2Cl2, rt) upon addition of Zn(OAc)2∙2H2O  aliquots (0.2 
equiv. until saturation at 1.0-1.2 equiv.). Inset: Absorption at 432 nm and fitting with a 1:1 binding model. d) Evolution of the ECD spectrum of (P,P)-1. 
Inset: Reversible ECD341nm switching process. e) Evolution of the fluorescence of (P,P)-1 (ex = 350 nm, 2.2  10
-5 M, CH2Cl2, r.t.).  
from meso-1 ligand upon treatment with 1 equiv. of I 25 
Zn(OAc)2·2H2O in CH2Cl2 (see Scheme 2). This complex was 
obtained quantitatively (Ka = 1.98  10
6 M-1) and was fully 
characterized (see ESI). Single crystals could be grown and the 
X-ray structure (P121/n1 space group, Scheme 2a) shows the 
pentacoordinated Zn centre, with two OAc and the terpy ligand in 30 
a cis geometry (U shape). Note that upon coordination, the meso-
1 ligand has kept its Cs symmetry but the helical angle of the 
aza[6]helicene parts has increased to 77.72°, certainly due to 
steric hindrance. Overall, upon coordination to the metal ion, the 
two aza[6]helicene moieties have fully rotated around the C–C 35 
bonds from one side of the central pyridyl ring to the other, thus 
inducing significant conformational change. 
 In a second stage, aliquots of Zn(OAc)2·2H2O were added to 
(M,M)- and (P,P)-1 and the complexation process (Figure 2a,b) 
was followed by UV-vis and ECD spectroscopy (0.2 equivalents 40 
of Zn(OAc)2 were added until saturation at 1.0-1.2 equiv.). Large 
changes were observed in the UV-vis spectrum of (P*,P*)-1# 
upon Zn(II) binding, as depicted in Figure 2c, with the presence 
of several isosbestic points, showing that the two species are in 
equilibrium. The solution turned from pale yellow to dark yellow 45 
colour. Curve fitting of the absorption variation at 432 nm 
revealed the formation of a 1:1 binding model with a high 
association constant (Ka = 1.16  10
6 M-1). Substantial 
modifications were also observed for chiroptical properties of 
(P,P)-1 upon Zn(II) binding (see Figure 1 and 2d). For example, 50 
the strong, positive ECD-active band at 341 nm decreases from 
+388 to +220 M-1 cm-1, a band around 310 nm increases and 
gains significant positive intensity (from -70 to +90 M-1 cm-1), 
and a new positive band of low intensity appears at 430 nm ( = 
+26 M-1 cm-1), while the molar rotation slightly increases ((P,P)-55 
1·Zn(OAc)2:  23D = +2300,  
23
D = +17300 (±5%, CH2Cl2, 2.18 
 10-4 M), vide supra). Similarly, the luminescence profile of 1 
significantly changes upon adding Zn(OAc)2, with the appearance 
of a structureless intense fluorescence emission at 480 nm ( = 
19%, = 3.4 ns, see Figure 2e) and CPL activity at this 60 
wavelength with glum values of +1.2  10
-3 and -1.4  10-3 for 
(P,P)-1·Zn(OAc)2 and (M,M)-1·Zn(OAc)2, respectively (see 
ESI). The emission colour turned from blue to green. 
 Calculations at the LC-PBE0*/SV(P) level14 with a continuum 
solvent model for CH2Cl2 reproduce these modifications well and 65 
link them predominantly to the large conformational changes in 
the structure of the ligand 1 upon Zn(II) coordination. The 
simulated ECD spectrum of ligand 1 in the cis conformation of 
the terpy unit indeed clearly resembles the one calculated for 
1·Zn(OAc)2 (Figure 1). Additionally, the Zn(II) complexation has 70 
a strong effect on the LUMO and LUMO+1 of 1 (both *), 
leading to a concentration of their density around the zinc ion in 
the terpyridine part of the ligand (see SI for the MO analysis).5d  
The HOMO and other high lying occupied -orbitals remain 
helicene-centered and therefore the complexation strongly 75 
increases the character of charge-transfer from the helicene to the 
terpyridine part of the ligand in the low-energy part of the 
spectrum.5d Note that no Zn orbitals were found to contribute to 
the -conjugated system of the helicene ligand, as expected for 
closed-shell d10 metal centers. The primary effect of the Zn 80 
moiety is therefore to activate the structural transformation of the 
aza[6]helicene fragments, rigidify the system, and induce charge-
transfer excitations within the ligand. The calculations also 
correctly reproduce changes in the S1-S0 (HOMO-LUMO) 
emission upon Zn(II) complexation, which is in line with the 85 
noticeable energetic stabilization of the LUMO in the complex 
relative to the pristine ligand: from 419 nm, glum = + 6.8  10
-3 
computed for (P,P)-1 to 452 nm, glum = + 1.1  10
-3 for (P,P)-
1·Zn(OAc)2 (vide supra, see ESI).  
In order to verify the reversibility of the Zn(II) binding 90 
process, N,N,N',N'-tetrakis(2-pyridylmethyl)ethane-1,2-diamine 
(TPEN) was utilized as a competitive ligand for zinc: upon 
treatment with TPEN, the system returned to its original state, i.e. 
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to the native chiral (P,P) and (M,M)-1 ligands. Up to 9-10 steps 
could be performed upon successive additions of 1 equiv. of 
Zn(OAc)2 and TPEN, following the ECD tuning at a selected 
wavelength where the changes are very high (for example  = 
175 M-1 cm-1 at 341 nm, see inset of Figure 2d).  Overall, this 5 
system is behaving as a chiroptical switch offering multi-output 
read-out (UV-vis, ECD, luminescence and CPL). Furthermore, 
the switching process triggers conformational changes and 
molecular motion around the Zn centre, from a clear trans (W-
shape) conformation in the free ligand to a cis (U-shape) one in 10 
the Zn-complex. To our knowledge, this constitutes a new type of 
helicene-based chiroptical switching.4 In conclusion, the 
preparation of unprecedented bis-helicenic terpy ligand has 
opened new perspectives in multifunctional chiral complexes and 
chiroptical switches; coordination to other metallic ions is under 15 
current investigation. 
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